The protegrin PG-1, belonging to the family of L-stranded antimicrobial peptides, exerts its activity by forming pores in the target biological membranes. Linear analogues derived from PG-1 do not form pores in the phospholipid membranes and have been used successfully to deliver therapeutic compounds into eucaryotic cells. In this paper, the translocation of PG-1 and of a linear analogue through artificial phospholipid membranes was investigated, leading to a possible mechanism for the activity of these peptidic vectors. We report here that [12W]PG-1, a fluorescent analogue of PG-1, is able to translocate through lipid bilayers and we demonstrate that this property depends on its secondary structure. Our results agree with the recent mechanism proposed for the translocation and permeabilisation activities of several helical and L-stranded peptides. In addition, our data corroborate recent work suggesting that certain protegrin-derived vectors enter into endothelial cells by adsorptive-mediated endocytosis. ß
Introduction
Protegrin-1 (PG-I) is an 18-amino-acid peptide isolated originally from porcine leucocyte cells [1] . This peptide displays a broad-range antimicrobial activity spectrum [1^3] and has, therefore, excellent potential for pharmaceutical uses. The structure of PG-1 in solution as determined by nuclear magnetic resonance (NMR) studies is a one-turn L-hairpin in which two antiparallel strands linked by a L-turn are stabilised by two disulphide bridges [4, 5] . The cationic nature of the peptide allows its interaction with the lipid matrix of bacterial membranes containing negatively charged lipids, but its antimicrobial activity itself depends on its ability to form pores in these membranes. Several studies have demonstrated that PG-1 is able to alter the permeability of cellular membranes [6] or of arti¢cial bilayers [7] . Structural investigations by NMR have indicated that this peptide should adopt a dimeric structure in a membrane-mimetic environment supporting a model in which the association of several dimers results in the formation of a pore [8] . In addition, recent work has provided evidence of the existence of two di¡erent states of PG-1 in a lipid bilayer, one corresponding to its parallel orientation on the surface of the membrane and the other corresponding to its transmembranal insertion [9, 10] .
It has been shown previously that disulphide bridges of protegrin are a prerequisite for its pore formation capability [6] . The linearisation of this peptide o¡ered the possibility of designing analogues able to interact with the cell surface but lacking the membrane-disrupting activity. One of these peptides, SynB1, was shown to enhance the uptake of doxorubicin into cultured multidrug-resistant K562 cells [11] and to increase its transport across the bloodb rain barrier in mouse and rat [12, 13] . Other vectors, belonging to di¡erent cell-permeable peptide families, have been developed recently for the intracellular delivery of therapeutic compounds in vitro and in vivo (see for review [14] and references therein). However, questions were raised about their mode of entry into cells, which does not seem to be via classic endocytosis [14] . For several cell-permeable peptides, it was proposed that they cross the lipid matrix of plasma membranes in an energy-independent manner to penetrate into cells [15, 16] .
We investigated the ability of a £uorescent analogue of PG-1 and of a £uorescent linear analogue to translocate from the outer to the inner lea£et of a membrane. It was demonstrated previously that the antimicrobial peptide tachyplesin I (TA-1), having a secondary structure similar to that of PG-1 [17] , is able to form transient anionic-selective pores and to translocate through phospholipid bilayers [18] . This pore formation^translocation mechanism also concerns natural helical peptides such as magainin [19] , mellitin [20] and mastoparan-X [21] . However, no data related to the translocation ability of PG-1 have yet been reported.
We demonstrate here by £uorescence spectroscopy that PG-1, but not its linear analogue, crosses the membrane of phospholipidic vesicles. In addition, we show that the translocation ability of PG-1 is coupled to its pore formation capacity and depends on its folding in a L-hairpin. This suggests that protegrin-derived vectors do not spontaneously cross the lipid matrix of plasma membranes to enter into cells.
Materials and methods
Fmoc-PAL-PEG-PS (High Load) and 9-£uorenyl-methyloxycarbonyl (Fmoc) amino acids were purchased from Perseptive Biosystems (Hamburg, Germany). Other reagents used for peptide synthesis included N,NP-diisopropylcarbodiimide (DIPCDI, Fluka), 1-hydroxybenzotriazole (HOBT, Perkin Elmer), N,N-diisopropylethylamine (DIEA, Fluka), benzotriazole-1-yl-oxy-tris-pyrrolidinophosphonium hexa£uorophosphate (PyBop, Novabiochem) and dimethylformamide (DMF, Perseptive Biosystems).
The lipid POPC (1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine) and POPG (1-palmitoyl-2-oleyl-snglycero-3-phosphoglycerol) were obtained from Avanti Polar Lipids (AL, USA).
and calcein were obtained from Molecular Probes (Eugene, OR, USA). Sodium dithionite, 2,2,2-tri£uoroethanol (TFE) and sodium dodecyl sulphate (SDS) were supplied by Sigma (St Louis, MO, USA). Sephadex G75 was purchased from Pharmacia Biotech (Uppsala, Sweden).
Peptide synthesis
The peptides were synthesised according to FmoctBu strategy using an AMS 422 (ABIMED, Germany). After peptide elongation, resin was treated with piperidine (20% in DMF) to deprotect the Nterminus of peptide, washed with DMF and treated with deprotecting mixture to cleave peptides from resin and deprotect the side-chains. The labelling of TMR-peptide was done in DMF by adding 5-(and-6)-carboxytetramethylrhodamine to the amino-terminal free peptide in presence of DIEA (2 eq) and PyBop (1.5 eq). The cyclisation of PG-1 and [12W]PG-1 by disulphide bridges was realised according to the protocol of Tam et al. [22] . Peptide puri¢cation was accomplished by reverse phase high performance liquid chromatography (Water-prep LC 40, Water) under TFA 0,01%/acetonitrile gradient condition. Puri¢cation, as assessed by reverse phase analytic chromatography (Beckman Gold equipped with a Diode Array detector), was over 95% for both peptides by the criterion of UV absorbance at 220, 280 and 540 nm when the peptides were labelled with TMR. The molecular masses were validated by MALDI-TOF spectrometry (Voyager Elite, Perseptive Biosystem, UK).
Vesicle preparation
For preparation of small unilamellar vesicles (SUVs), a lipid ¢lm of the desired composition was dried for 3 h and then suspended in bu¡er (20 mM Tris, 150 mM NaF and 0.1 mM EDTA (pH 7.4)) to give a ¢nal concentration between 25 and 30 mM. The suspension was sonicated in ice-cold water for 25 min using a titanium tip ultrasonicator. Titanium and lipid debris were removed by centrifugation at 100 000Ug. Dynamic light-scattering measurements (Brookhaven Instruments, USA) con¢rmed the existence of a single population of vesicles (more than 95% of mass content) with a mean diameter of 31 þ 1 nm. For preparation of large unilamellar vesicles (LUVs), the lipid suspension in bu¡er (20 mM Tris, 150 mM NaCl and 1 mM EDTA (pH 7.4)) was freeze-thawed for ¢ve cycles and then extruded through polycarbonate ¢lters (0.1 Wm pore size) 21 times. The lipid concentration was determined in duplicate by phosphorus analysis as described in [23] .
Peptide binding
Fluorescence measurements were performed in 3-ml quartz cells at 25 þ 0.1³C under constant magnetic stirring using a SLM AB-2 spectro£uorometer (SLM Instruments, Urbana, IL, USA). For recording the emission spectra of peptide, excitation was set at 280 nm. Both excitation and emission band-pass were set at 4 nm. For each measure, the baseline spectra recorded in the absence of peptide were subtracted from the peptide spectra.
Dye release
Dye-entrapped LUVs were prepared with a lipid ¢lm of desired composition by the use of 70 mM calcein in bu¡er (pH was adjusted to 7.4 with 1 M NaOH) as a hydrating solution. Calcein-entrapped vesicles were separated from free calcein on a Sephadex-G75 column (18U1 cm). The release of calcein from LUVs was monitored by £uorescence at an emission wavelength of 520 nm (excitation wavelength of 490 nm). The maximum £uorescence intensity corresponding to 100% leakage was determined by the addition of 10 Wl of 10% w/v Triton X-100 to 3 ml of the sample. The apparent percent leakage value was calculated according to 100U(F3F 0 )/ (F max 3F 0 ). F and F max correspond respectively to the £uorescence intensity before and after the detergent addition. F 0 represents the £uorescence of the intact vesicles. The temperature was monitored at 25 þ 0.1³C.
Measurement of translocation
Symmetrically labelled LUVs were prepared by hydrating the lipid ¢lm composed of POPC, POPG and DNS-PE (70:15:15 mol/mol/mol). The observation of the £uorescence intensity of the Trp residue (328 or 335 nm) upon excitation at 280 nm allows to monitor the resonance energy transfer (RET) from the Trp residue of the peptide to the dansyl £uoro-phore in the membrane. The temperature was controlled at 25 þ 0.1³C.
Dithionite ion permeability
A lipid ¢lm composed of POPC/POPG/NBD-PE (7:3:0.05 mol/mol/mol) was resuspended with the bu¡er and freeze-thawed for ¢ve cycles. Small aliquots of the multilamellar vesicles (MLVs) were added to the bu¡er (control) or injected into a peptide solution in the presence of 10 mM sodium dithionite (freshly prepared at 1 M in 1 M Tris, pH 8.8). The £uorescence intensity of NBD at 530 nm (excited at 450 nm) was monitored at 25 þ 0.1³C.
Circular dichroism (CD) measurement
Peptide CD spectra were obtained on a Jobin Yvon CD6 spectropolarimeter. The spectra were scanned at room temperature in a quartz optical cell of 0.02 cm path length. Baseline spectra for each solvent or vesicle suspension were obtained prior to the peptide spectra. Each peptide was at a concentration of 75U10 36 M in bu¡er (150 mM NaF, 20 mM Tris, 0.1 mM EDTA), in TFE/bu¡er mixture (v/v 1:1) or in presence of SDS (0.5%). To measure spectra with SUVs, the concentration of peptide was decreased to 50U10 36 M 31 to ensure complete saturation of peptides with SUVs and to reduce the absorption and di¡usion caused by the presence of phospholipid vesicles. When the peptide adopted a preferential helical structure, the helical content was determined from the mean residue ellipticity [3] at 222 nm according to the relation
where [K] is the amount of helix [24] .
Flow cytometry of cell-association of peptide
K562 cells were cultured in RPMI supplemented with 10% foetal bovine serum. Cells were diluted at 0.3U10 6 cells ml 31 1 day before the experiment. Cell association was measured by £ow cytometry using a FACSCalibur (Becton Dickinson, USA). TMR-labelled peptides (1 WM) were incubated with K562 cells (5U10 5 cells per ml) in Opti-MEM medium at 37³C for various periods of time (¢nal volume was 0.5 ml). Thereafter, the cells were washed twice and then resuspended in 0.5 ml of ice-cold PBS for FACS analysis. Cell-associated £uorophores were excited at 488 nm and the £uorescence of TMR was measured at 575 nm. A histogram of £uorescence intensity per cell (1U10 4 ) was obtained and the calculated mean of this distribution was considered as representative of the amount of cell-associated peptides.
Results

Design and secondary structure of peptides
To measure the interaction of native PG-1 with phospholipidic vesicles and its translocation ability, we synthesised a £uorescent analogue termed [12W]PG-1 (Fig. 1) . This peptide corresponds to PG-1 in which an aromatic residue (Phe) located at position 12 was substituted by a similar but £uores-cent residue (Trp). We then designed a linear analogue named PG-AL deriving from [12W]PG-1 by substituting all Cys residues involved in disulphide bridges by either alanine or leucine. These residues (Ala at position 6 and 13, Leu at position 8 and 15) were carefully chosen in order to have a linear analogue of [12W]PG-1 with a similar theoretical hydrophobicity. For both peptides, we have calculated the mean residue hydrophobicity GHf according to Eisenberg et al. [25] and using the hydrophobicity scale of Wimley and White [26] . The PG-AL associated to a calculated GHf value equal to 0.52 is theoretically slightly more hydrophobic than [12W]PG-1 (GHf = 0.47). The reference peptide SynB1 is associated to a GHf value equal to 0.33.
We checked the secondary structure of [12W]PG-1 by recording its CD spectrum as well as that of PG-1 in bu¡er. The spectrum of both peptides showed a minimum around 200 nm and a maximum at 230 nm (Fig. 2) , characteristic of a L-hairpin structure [9] . The slight di¡erence in conformation and/or CD contribution of di¡erent aromatic groups in PG-1 and [12W]PG-1 could explain the small di¡erence in curve intensities and shapes observed between the two spectra [27] . As expected, the PG-AL peptide adopts a random coil conformation as indicated by its CD spectrum that exhibited a minimum at 198 nm (Fig. 2) .
Cell uptake of peptides
We incubated the £uorescent TMR-peptides with K562 cells at 1 WM for various times at 37³C to measure the kinetics of cell uptake of peptide by £ow cytometry. Fig. 3 shows that the kinetics of cell-uptake of linear peptides SynB1 and PG-AL reach a plateau after 1 h and indicate that PG-AL is better internalised than SynB1. The cell uptake of [12W]PG-1 was somewhat di¡erent since it did not reach a ¢nal plateau, even after 2 h. In addition, we observed that a large number of cells becoming nonviable after incubation with high concentrations (3 WM) of this cyclised peptide.
Peptide interaction
The change of Trp £uorescence emission spectra upon binding to phospholipid vesicles has been widely used to demonstrate the interaction of peptides with phospholipids [27, 28] . Fig. 4A ,B show, for both peptides, a blue-shift of the wavelength of maximum £uorescence emission when POPC/POPG (70:30 mol/mol) LUVs were added to the peptide solution, indicating that both peptides interacted with the membranes. We have plotted the wavelength corresponding to the maximum £uorescence intensity of Trp residue as function of the lipid-to-peptide molar ratio (Fig. 4C ) to indicate that a major fraction of [12W]PG-1 and PG-AL peptides was in a lipid-bound form at a L/P value of 60 and 130, respectively. It should be noted that the blue-shift observed with [12W]PG-1 is accompanied by a decrease in the £uorescence intensity of Trp residue. In contrast, the £uorescence intensity of PG-AL peptide increases upon binding to vesicles.
Permeabilisation
A dye release assay was performed to examine the membrane permeabilising activity of both peptides. It was measured by an increase in £uorescence intensity due to relief from the self-quenching of calcein concentrated (70 mM) within the LUVs (data not shown). The relationship between apparent percent leakage value and the peptide-to-lipid molar ratio is reported in Fig. 5 and shows that [12W]PG-1 induces of a second population of dansyl-free LUVs (POPC/POPG 70:30) was added as indicated by the arrows. An increase in intensity indicates the relief from RET caused by the redistribution between the two vesicle populations of the peptide molecules which had been bound to the outer surface of the ¢rst vesicle. The di¡erence (as labelled by vF) between ¢nal £uorescence intensity (F 2 ) and the £uo-rescence intensity (F 2 P) when both populations of vesicles were simultaneously added at time zero indicates the fraction of peptide which has translocated into the inner lea£et during the incubation time. The trace is representative of ¢ve independent measurements. a leakage of calcein from vesicles at very low peptideto-lipid molar ratio. In contrast, PG-AL only permeabilises the membranes e¡ectively at very high P/L values.
Peptide translocation
The translocation was detected according to the protocol described by Matsuzaki et al.
[18^21] based on the evaluation of the amount of untranslocated peptides remaining in the outer lea£et of the membranes. The untranslocated peptides can be readily removed from the vesicle surface by extraction with a large excess of a second population of vesicles. The resonance energy transfer (RET) from the Trp residue of the peptide to the dansyl chromophore (DNS-PE) incorporated into the membrane of the ¢rst population of vesicles allows determination of the unremovable (i.e., translocated) fraction. At time zero, when dansyl-labelled vesicles (115 WM) were added to a peptide solution (1 WM), a decrease in Trp £uo-rescence was seen indicating RET due to peptide binding to the membrane (Fig. 6A) . After 1 min of incubation, a second population of dansyl-free vesicles (DNS-PE was substituted by POPG) was added in large excess (more than 5-fold). The peptide molecules, which had been bound to the outer lea£et, were redistributed between the two vesicle populations, resulting in a relief from RET and in a fast increase in the £uorescence intensity. In the case of [12W]PG-1, the increased £uorescence intensity was, however, smaller than the intensity obtained when both vesicle populations were simultaneously added to the peptide solution at time zero (as indicated by vF). In addition, the ¢nal £uorescence decreased with the incubation time, suggesting that a fraction of the peptides became progressively unexposed to the outer lea£et and therefore untransferable to the second vesicles. This indicates a time-dependent peptide translocation. It should be noted that the slow increase of £uorescence observed after addition of the second vesicle population could be attributed to the cross-back of peptides through the membrane of the ¢rst vesicle population [18, 19, 21] . The translocation assay performed with PG-AL showed that no change of £uorescence was observed as a function of time (Fig. 6B) . This indicates that PG-AL remains on the outer lea£et of the ¢rst population of vesicles and does not translocate through the phospholipid bilayer.
The [12W]PG-1 peptide is entirely protected from the enzymatic action of trypsin as measured by RET at 510 nm in presence of DNS-PE containing vesicles (data not shown). This protection against trypsin treatment, previously observed for tachyplesin I [18] , did not allow us to investigate the existence of the [12W]PG-1 translocation through the lipid membrane according to the protocol of Matsuzaki et al. [19, 21] . We therefore con¢rmed the translocation of [12W]PG-1 by using a dithionite-permeability assay [20, 21] . Fig. 7 shows that the addition of sodium dithionite, a membrane-impermeable compound, to NBD-PE containing MLVs irreversibly quenches the £uorophore localised on the outermost lea£et (i.e., 15% of the initial NBD £uorescence). The addition of [12W]PG-1 allowed the reducing ion to react with more than 85% of the NBD group within 6 min. If the peptide had permeabilised only the outermost bilayer, the reagent could have reacted with the £uo-rophore facing the ¢rst interlamellar space, resulting in a quenching less than 75% [20, 21] . This suggests that the [12W]PG-1 molecule ¢rst translocates across the outermost bilayer and then destabilises the inner bilayer. Fig. 8 shows a comparison between the kinetics of membrane permeabilisation induced by the [12W]PG-1 and the kinetics of translocation of this peptide determined at the same L/P value of 115. To evaluate the percent translocation value, we used the £uorescence intensity measured 60 s after the addition of dansyl-free vesicles (Fig. 6A) . The peptide translocation is coupled with the pore formation estimated from the apparent dye release value, suggesting that [12W]PG-1 crosses the membrane by a pore formation^translocation mechanism.
Correlation between translocation and membrane permeabilisation
Secondary structure of peptides in several environments
CD spectroscopy was used to determine the secondary structure of the peptides in several media. presence of POPC/POPG (70:30 mol/mol) SUVs, we report changes of the CD spectrum similar to those observed in the presence of SDS. As indicated previously in Fig. 2 , the PG-AL peptide has no ordered secondary structure in bu¡er. In the presence of TFE, the CD spectrum of peptide showed minima at 208 and 222 nm and a maximum at 193 nm, characteristic of a right-handed K-helical conformation (Fig. 9B) . From the ellipticity value at 222 nm (see Section 2), we evaluated the helical content of peptide to 45.4%. We have also investigated the secondary structure of the peptide in the presence of SDS micelles or upon binding to lipid vesicles and we show that it adopts preferentially a helical conformation with, respectively, a helical content of 21% and 26% (Fig. 9B ).
Discussion
We have investigated whether protegrin (in a £uo-rescent form) and a linear analogue PG-AL are able to pass across a lipid bilayer. This study allows us to better understand the relationship between the folding of protegrin and its permeabilisation mechanism upon binding to lipidic membranes. In addition, this study has provided information about the mode of cell uptake of SynB peptides derived from PG-1 by linearisation [11] . It has been previously proposed that the cell uptake of peptides such as penetratin or transportan occurs by crossing the lipid matrix of plasma membranes in an energy-independent manner [29, 30] . Thus, our studies allow us to evaluate whether the cell uptake of peptides derived by linearisation of protegrin depends on their translocation through the lipid matrix of the plasma membrane.
We have synthesised a £uorescent analogue of protegrin PG-1, named [12W]PG-1, following the synthesis protocol used previously to produce the protegrin [4, 6] . The substitution of residue Phe by Trp at position 12 within the primary sequence does not a¡ect the formation of the L-hairpin turn and disulphide bridge formation, as indicated by the similarity between the CD spectra recorded for PG-1 and [12W]PG-1. The spectra obtained were similar to those reported earlier for native PG-1 [9] . As expected, the PG-AL peptide, a linear analogue of
[12W]PG-1, has no de¢ned secondary structure, con¢rming that the two disulphide bridges are crucial for stabilising the protegrin folding.
By using £ow cytometry, we have compared the internalisation of PG-AL and [12W]PG-1 into K562 cells to our reference peptide SynB1 [11^13]. The cell-uptake of PG-AL and SynB1 exhibits a similar kinetic pro¢le, whereas that of [12W]PG-1 is different. This result indicates ¢rst that PG-AL is representative of the SynB family in term of cell-uptake and suggests that the linear and cyclised peptides enter into cells by a di¡erent mechanism. This was illustrated by the observation made during internalisation assay indicating that only the [12W]PG-1 induced cell death when its concentration was slightly increased (data not shown). Therefore, it is very dif¢cult to compare the internalisation of PG-AL and [12W]PG-1 since for this latter peptide, cell viability might be a¡ected. At opposite, we propose that the strong internalisation of PG-AL compared to those of SynB1 could be due to its higher hydrophobicity, since we have demonstrated that this physico-chemical property could govern the cell uptake of linear peptidic vectors [31] .
We have studied the interaction of [12W]PG-1 and PG-AL with membranes containing 30% (mol/mol) negatively charged phospholipids. The interaction of both peptides with the lipid bilayers was monitored by the blue-shift in Trp £uorescence emission spectra due to the re-localisation of this residue from a polar to a hydrophobic environment. The interaction between [12W]PG-1 and lipids was strong as indicated by the low L/P for which we observed a complete saturation of peptide by vesicles. Compared to [12W]PG-1, the PG-AL peptide seems to have a lower lipid-binding a¤nity, suggesting that the folding of protegrin favours its interaction with phospholipids.
Using a dye release assay, we have shown that [12W]PG-1 induces permeabilisation of membranes at high lipid-to-peptide molar ratio (L/P = 125 for 75% permeabilisation) consistent with a permeabilising mechanism involving the formation of pores [6, 7] . Circular dichroism spectra suggest that the Lsheet content of [12W]PG-1 increases upon binding to phospholipid vesicles or in the presence of SDS micelles. This observation agrees with 1 H NMR results reported by Roumestand et al. [8] who pro-posed previously that PG-1 in dodecylphosphocholine micelles is better structured than in water. Thus, the formation of a multimeric pore could depend on the slight rearrangement of the L-hairpin structure of protegrin. In addition, an unusual quenching of Trp £uorescence was observed when the peptides interacted with lipids. One explanation could be that this quenching is due to the close contact between the Trp residue of a [12W]PG-1 monomer and an amino acid belonging to a second one.
The linear analogue of [12W]PG-1 probably does not form pores, as indicated by its low permeabilising activity observed at low lipid-to-peptide molar ratios. In addition, cytotoxicity assays carried out with K562 cells incubated with peptides for 48 h (Mazel et al., unpublished data) indicate that the PG-AL peptide is 4-fold less cytotoxic than [12W]PG-1 and PG-1 (these latter two peptides have the same cytotoxicity). This could re£ect the fact that PG-AL has a lower permeabilising potential against natural membranes than [12W]PG-1.
We have assayed the translocation of [12W]PG-1 according to the protocol previously described by Matsuzaki et al. [18^21] . We report here that [12W]PG-1 translocates rapidly from the outer to the inner lea£et of phospholipid bilayer at a high lipid-to-peptide molar ratio. In contrast, the PG-AL peptide does not cross the membrane indicating that the linearisation of [12W]PG-1 suppresses its permeabilising potency as well as its ability to translocate through a lipid bilayer. This agrees with previous observations demonstrating that a linear analogue of tachyplesin, forming a L-sheet at the surface of the phospholipidic bilayer, is not able to pass across membranes [18] . In our study, circular dichroism indicates that, although PG-AL adopts a partial helical conformation in an K-helical promoting medium such as TFE, it has no predominant conformation in a membrane-mimetic environment or upon binding to lipid vesicles. The folding of the protegrin in a L-hairpin, stabilised by disulphide bridges, seems to be a clear determinant for its ability to cross phospholipid membranes.
The translocation of [12W]PG-1 is coupled to its permeabilisation activity, suggesting that protegrin is redistributed between the two lea£ets after the formation of a transient pore in the membrane. It should be noted that the translocation observed for
[12W]PG-1 and previously for TA-1 [18] occurs at a similar L/P value in the presence of vesicles having a similar phospholipid composition. In addition, the dynamic behaviour of protegrin during pore formation and pore deactivation is consistent with the coexistence of two states of protegrin in the phospholipid bilayer corresponding to a surface-absorbed state and a membrane-spanning state [9] . Moreover, recent X-ray di¡raction studies have suggested that protegrin forms a toroidal pore in the membrane [32] . The peptide magainin has also been shown to form toroidal pores, i.e., a multimeric organisation constituted by heads of lipids and peptides localised at the lipid/water interface [33] . In this model, the lea£ets of the bilayer fold over onto each other, producing a pore which looks like the inside of a torus lined with peptides (`wormhole' model). It was clearly demonstrated that magainins are able to translocate across membranes [19, 34] . Thus, our data support the view that PG-1 interacts with and translocates through the lipid membranes following the`wormhole' model.
The membrane permeabilisation mechanism of protegrin seems to correspond to the model proposed for tachyplesin and other peptides by Matsuzaki [34] . We demonstrate that this property of PG-1 depends on its secondary structure, meaning that the linear analogues derived from this peptide cannot spontaneously cross a lipid membrane. Thus, we propose that the linearisation of PG-1 generates peptidic vectors which are able to interact with the cellular membranes but which cannot pass through their lipidic matrix. The results obtained by the internalisation assays suggest that the linear and disul¢de bridged analogues of PG-1 have a di¡erent mode of cell uptake. Therefore, this could mean that the penetration of these linear peptides into intact cells depends on an energy-dependant pathway. A recent work supports this view by indicating that the internalisation of SynB1 into the endothelial cells of the bloodb rain barrier may involve adsorptive mediated endocytosis [13] . However, we cannot exclude the possibility that the cell uptake of SynB peptides involves, in part, an unexplained energy-independent pathway, as observed for other cationic peptidic vectors [35] . Our continuing studies are aimed at better understanding the cellular import of linear analogues of protegrin.
